No Data
Kangtuo Medical (688314.SH) had a net income of 24.0482 million yuan in the first quarter, reflecting a year-on-year growth of 20.63%.
On April 29, Gelonghui reported that Kangtuo Medical (688314.SH) published its first quarter report, achieving total operating income of 82.491 million yuan in the first quarter of 2025, a year-on-year increase of 17.98%; the Net income attributable to shareholders of the parent company was 24.0482 million yuan, a year-on-year increase of 20.63%; the EPS was 0.3 yuan.
Kangtuo Healthcare: Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the first quarter of 2025
Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the first quarter of 2025
Kangtuo Medical (688314.SH): The Business volume of imports and exports to the USA is relatively low.
On April 16th, Gelonghui reported that Kangtuo Medical (688314.SH) stated on the investor interaction platform that the volume of Business exported and imported to the USA accounts for a relatively low proportion, and the current environment has a minor impact on the company's overall Operation. With the deeper implementation of centralized procurement in the domestic neurosurgical cranial repair and fixation field, domestic brands have taken a dominant position in the market.
Kangtuo Healthcare: Summary of the 2024 Annual Report of Xi\'an Kangtuo Medical Technology Co., Ltd.
Kangtuo Healthcare: Xi\'an Kangtuo Medical Technology Co., Ltd. 2024 Annual Report